Chronic hepatitis F1: Liver or gallbladder problem with acid reflux, frequent vomiting, a bitter tasted and stickiness in the mouth, foul-smelling burping, herpes, distension in the rib cage and stomach area.
1. Liver disease: Seven reports on 533 patients with various liver disease ailments, taking F1 formula from two to 15 months found 94 cured (17.64%), 91 significantly improved (17.07%), 300 improved (56.29%) and 48 did not improve (9.01%). A report on 129 positive HBsAg patients, divided into a treatment group taking F1 for up to two months(n=83) and a comparison group (n=46) taking regular western medicine for the same period of time showed the following results: HBsAg turned negative: 44 vs. 6 (53.01% vs. 13.04%), P<0.001. Total effective rate was 91.6% vs. 36.9%, P<0.01. Another 36 hepatitis B patients took F1 and its modifications from one to three months, and 29 were cured (80,55%), 5 improved (13.89%) and only two patients (5.56%) did not improve.
2. Anti-ulcer: In lab tests, F1 can prevent gastric ulcers from various chemical damages in test animals, P<0.05 or P<0.01. F1 could reduce the MAO (maximum acid output) and total gastric juice, while increasing the protection strength of gastric mucus and wall. In three clinical reports, 97 CAG (chronic atrophric gastritis) patients taking F1 up to three months, the results were: 33 cured (34.02%), 24 significantly improved (24.74%), 33 improved (34.02%) and only 7 patients did not improve (7.22%). Of 18 another gastric ulcer patients taking F1 for three months, only 3 did not improve; the other 15 were either cured or improved.
3. PMS: Of 36 females, from 25 to 40 years old all having been treated with regular western medicine to little effects, 26 (72.2%) significantly improved and 10 (27.8%) were improved after taking the F1 formula.
4. Herpes: Of 336 patients using F1 from 7 to 14 days, 318 were cured (94.64%) and 18 significantly improved (5.36%). A report on 100 patients who were divided into a treatment group (n=58) and a comparison group (n=42) using Vit. B 100 mg IV injections and Vit. B.12 at 200ug showed: Cured: 56 vs. 30 (96.55% vs. 71.42%), improved: 2 vs. 5 (3.45% vs. 11.90%) and 7 cases in comparison group did not improve ( 0% vs. 16.67%). There is a significant difference between two groups.
Toxicity and side effects: There is no death after 72 hours at the dosage of 40g/Kg and 50g/Kg. The LD50 can not be measured. There is no known toxicity or side effects to the F1 formula.
